As a consequence, in the present cohort of individuals at low risk of severe liver damage, IL32 performance as a biomarker to discriminate severe fatty liver disease was at best moderate, although we confirmed previous data indicating that a score incorporating IL32 could predict liver damage related to metabolic dysfunction [20]. This evidence concerns the gene IL32 and fatty liver disease.